Thompson, K.S., and Liu, W.H
SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
SLU-PP-332 functions as a small molecule activator of ERR (estrogen-related receptor) family transcription factors, specifically targeting pathways related to cellular energy output and oxidative capacity
This compound is frequently used in studies exploring transcriptional regulators of energy output and endurance, particularly in muscle tissue
Dr.Terranas knowledge in his specialty in addition to professionalism, patience and bedside manner is highly recommended
References Smith, J., & Lee, A